Rosen, leading investor counsel, encourages altimmune, inc. investors to inquire about securities class action investigation - alt

New york , feb. 16, 2024 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of altimmune, inc. (nasdaq: alt) resulting from allegations that altimmune may have issued materially misleading business information to the investing public. so what: if you purchased altimmune securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
ALT Ratings Summary
ALT Quant Ranking